Prevalence, pharmacological treatment, and control of cardiometabolic risk factors among older people in central Stockholm: a population-based study. - Wikidata - awgldk - TriplyDB

Prevalence, pharmacological treatment, and control of cardiometabolic risk factors among older people in central Stockholm: a population-based study.

Prevalence, pharmacological treatment, and control of cardiometabolic risk factors among older people in central Stockholm: a population-based study.

http://www.wikidata.org/entity/Q35208862

about

Prevalence and Patterns of Chronic Disease Pairs and Multimorbidity among Older Chinese Adults Living in a Rural Area.

P2860

Q35783758-3D5A5303-D65A-4303-A1E0-6E07569D3C8B

P2860

Prevalence, pharmacological treatment, and control of cardiometabolic risk factors among older people in central Stockholm: a population-based study.

http://www.wikidata.org/entity/Q35208862

description

2015 nî lūn-bûn

@nan

2015 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի մարտին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Prevalence, pharmacological tr ...... olm: a population-based study.

@ast

Prevalence, pharmacological tr ...... olm: a population-based study.

@en

type

label

Prevalence, pharmacological tr ...... olm: a population-based study.

@ast

Prevalence, pharmacological tr ...... olm: a population-based study.

@en

prefLabel

Prevalence, pharmacological tr ...... olm: a population-based study.

@ast

Prevalence, pharmacological tr ...... olm: a population-based study.

@en

P1433

Q35208862-53A5ABD5-861E-47CC-852D-ED1B82ECE4F0

P1476

Q35208862-35D91DED-BCF2-4AF0-BC67-2F7F9D8B5B4B

P2093

Q35208862-01675F5B-1A2C-43EE-B10F-67E1F731D3C0

Q35208862-4F09BB14-F4EA-47EC-A584-A2C4FC5C702D

Q35208862-53CEDFD3-F9BE-4412-B915-0BD27E3687A7

Q35208862-68CD2288-B50B-4301-A4F9-6ACC78377013

Q35208862-69C47796-C370-44E8-A7E8-568F1424ED11

Q35208862-776FD591-8B4F-4500-B2EC-763D2ABCEA5B

Q35208862-C75BFE25-ABD1-4955-AA8B-437E75DDA606

P2860

Q35208862-001B4DA4-BB98-463F-8BAB-E54D61DF6DF8

Q35208862-17470FEB-0A83-4482-948C-C640E7DD6447

Q35208862-1DABE258-2CD9-40FB-B664-F9650514BCF2

Q35208862-1E85A858-192B-42E3-B5A5-DF21DE6629E9

Q35208862-273BEA16-515F-4306-9068-C716AD9A02B3

Q35208862-301A00ED-9A83-433E-856C-BE33916DF8B7

Q35208862-38663438-3659-4BF2-B61C-CC7B7FE21E83

Q35208862-39904463-7ADC-44FC-B155-9824A59C6CC4

Q35208862-3CF741A0-22F2-4150-9C29-6EC5C51115C0

Q35208862-3D9A2187-645D-4823-8EBB-C62907AEC868

P304

Q35208862-D9ED88A8-38AD-4216-8B79-BC8BC513C9B2

P31

Q35208862-8235373B-6CD3-4F63-9C35-8CE11DE38451

P356

Q35208862-1A4B40C9-F3F3-4B56-B4E1-4F175D127FE9

P407

Q35208862-EFAA57AC-F912-4F88-8C8D-2B792A28CE1E

P433

Q35208862-F774E1A4-2061-433B-90EF-3DF08814AD42

P478

Q35208862-06B1BE8E-26C4-4AA2-AB7A-2E795F54D379

P50

Q35208862-7C4EAADF-1DF1-4B00-A489-02D0E73A376F

P577

Q35208862-916C69F2-DB98-4B3F-AD8F-8012FE012BBC

P5875

Q35208862-0BB8A44D-2EFE-46B3-8C52-E73CD659AB91

P698

Q35208862-7F9BC141-4577-4F07-B3D3-065C6D72C875

P932

Q35208862-344BDA91-E269-4B3D-9AF2-8553358CBC3B

P356

JOURNAL.PONE.0119582

P1433

P1476

Prevalence, pharmacological tr ...... olm: a population-based study.

@en

P2093

Chengxuan Qiu

http://www.w3.org/2001/XMLSchema#string

Francesca Mangialasche

http://www.w3.org/2001/XMLSchema#string

Kristina Johnell

http://www.w3.org/2001/XMLSchema#string

Laura Fratiglioni

http://www.w3.org/2001/XMLSchema#string

Rui Wang

http://www.w3.org/2001/XMLSchema#string

Weili Xu

http://www.w3.org/2001/XMLSchema#string

Yajun Liang

http://www.w3.org/2001/XMLSchema#string

P2860

Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure

Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010

Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report

Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults--The Evidence Report. National Institutes of Health

2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8)

Standards of medical care in diabetes--2013

The global cardiovascular risk transition: associations of four metabolic risk factors with national income, urbanization, and Western diet in 1980 and 2008.

A validation study of patient interview data and pharmacy records for antihypertensive, statin, and antidepressant medication use among older women.

Ageing populations: the challenges ahead.

High total serum cholesterol, medication coverage and therapeutic control: an analysis of national health examination survey data from eight countries.

P304

e0119582

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0119582

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P50

Anna-karin Welmer

P577

2015-03-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

274008505

http://www.w3.org/2001/XMLSchema#string

P698

25799502

http://www.w3.org/2001/XMLSchema#string

P932

4370718

http://www.w3.org/2001/XMLSchema#string